Abiopharma

📋 Jacob DeWitte (CEO / Director / 10% Shareholder) plans to sell 400K shares of Oklo, Inc. (at $38.83 each, total $15.5M) Filed: Aug 03, 2026 | ID: 000770

(99% Neutral) INVESCO MORTGAGE CAPITAL INC. (IVR) Files Form 8-K

Kim Joo Mi 🔴 sold 3.8K shares of QUALYS, INC. (QLYS) at $144.75 Transaction Date: Aug 01, 2026 | Filing ID: 000019

Viemed - Viemed Healthcare Announces Second Quarter 2026 Financial Results

(99% Neutral) SUPERNUS PHARMACEUTICALS, INC. (SUPN) Files Form 8-K

POSEY BRUCE K 🔴 sold 2.3K shares of QUALYS, INC. (QLYS) at $144.75 Transaction Date: Aug 01, 2026 | Filing ID: 000022

(99% Neutral) VENU HOLDING CORP (VENU) Announces Business Combination

Director Cates G. Staley 🟢 acquired 274 shares (1 derivative) of AFFILIATED MANAGERS GROUP, INC. (AMG) Transaction Date: Jul 30, 2026 | Filing ID: 000080

Director HOOLEY JOSEPH L 🟢 acquired 49 shares of IDEXX LABORATORIES INC /DE (IDXX) at $558.80 Transaction Date: Jul 30, 2026 | Filing ID: 000117

Rosen Law Firm Urges Avis Budget Group, Inc. (NASDAQ: CAR) Stockholders to Contact the Firm for Information About Their Rights

Paycom Announces Quarterly Cash Dividend

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Highland Opportunities and Income Fund Announces the Regular Monthly Distribution

BEASLEY BROADCAST GROUP TO REPORT Q2 2026 FINANCIAL RESULTS, HOST CONFERENCE CALL AND WEBCAST ON AUGUST 10

Black Stone Minerals, L.P. Reports Second Quarter Results